ConductScience.org, home

Paper67885

An evaluation of leukocyte adherence inhibition in the immunodiagnosis of colorectal cancer.

Halliday WJ and 3 others. Cancer Res, 1977. Cited by 41 papers, by iCite.

Cite this record

ConductScience Library. An evaluation of leukocyte adherence inhibition in the immunodiagnosis of colorectal cancer. Papers, record 67885. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/67885

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
An evaluation of leukocyte adherence inhibition in the immunodiagnosis of colorectal cancer.
PubMed
Journal
Cancer Res
PubMed
Year
1977
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
41
iCite
Relative citation ratio, by iCite
1.55
iCite
Revised in PubMed
2007-11-15
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Halliday WJW J
2Maluish AEA E
3Stephenson PMP M
4Davis NCN C

Source PubMed

Download CSV of authors

Topics24

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AdenocarcinomaMajor topic
Colonic NeoplasmsMajor topic
Immunologic TechniquesMajor topic
Leukocyte Adherence Inhibition TestMajor topic
Rectal NeoplasmsMajor topic
Adult
Aged
Antibodies, Neoplasm
Antigens, Neoplasm
Binding, Competitive
Diverticulum
Epitopes
Evaluation Studies as Topic
False Positive Reactions
Female
Gastrointestinal Diseases
Humans
Immunity
Immunity, Cellular
Leukocytes
Male
Middle Aged
Recurrence
Remission, Spontaneous

Source PubMed

Download CSV of topics

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 41 citations.

PMIDTitleJournalYearIn PapersSource
7059471Blood basophils in lung cancer.Br J Cancer1982https://conductscience.org/library/papers/7059471PubMed
6177329Cellular immunity to encephalitogenic peptide in tumour-bearing mice.Br J Cancer1982https://conductscience.org/library/papers/6177329PubMed
4042416Successful tumour immunotherapy: possible role of antibodies to anti-inflammatory factors produced by neoplasms.Clin Exp Immunol1985https://conductscience.org/library/papers/4042416PubMed
3782265Leukocyte adherence inhibition in patients with nonmalignant disorders of the colon and colorectal cancer.J Cancer Res Clin Oncol1986https://conductscience.org/library/papers/3782265PubMed
3594486Depression of cell-mediated immunity by tumour cell products: induction of resistance by immunotherapeutically active extracts of bovine ocular squamous cell carcinoma.Cancer Immunol Immunother1987https://conductscience.org/library/papers/3594486PubMed
497111Bovine ocular squamous-cell carcinoma: lymphocyte response to phytohaemagglutinin and tumour antigen.Br J Cancer1979https://conductscience.org/library/papers/497111PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/67885

GET https://conductscience.org/api/papers/v1/67885/authors